Shandong Wohua Pharmaceutical Co., Ltd.

002107

CNE000001QB8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 20/06/2024 BST			5-day change	1st Jan Change
4.05 ^CNY	+1.25%		-3.34%	-33.28%

04-26	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shandong Wohua Pharmaceutical Co., Ltd. Approves Cash Dividend for 2013; Announces Executive Appointments

June 26, 2014

Shandong Wohua Pharmaceutical Co., Ltd. at its Annual General Meeting of 2013, held on June 26, 2014, approved cash dividend per 10 shares (tax included) of CNY 0.60 for 2013.

The company approved the appointment of Wang Jiong as non-independent director and Wang Guihua as independent director.

Latest news about Shandong Wohua Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/07/23	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	15/07/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	15/04/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Executive Appointments	11/02/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	20/01/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/07/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/04/21	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. cancelled the acquisition of Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd..	26/03/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	20/01/21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	15/10/20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	15/07/20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	28/04/20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	28/04/20	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. entered into a share transfer agreement to acquire Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd. for CNY 90 million.	27/03/20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	28/10/19	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	28/08/19	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	28/04/19	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	31/01/19	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Earnings Results for the Third Quarter and Nine Months Ended September 2015	09/10/15	CI

Chart Shandong Wohua Pharmaceutical Co., Ltd.

Duration

Period

Chart Shandong Wohua Pharmaceutical Co., Ltd.

More charts

Company Profile

Shandong Wohua Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese traditional patent medicines. The Company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Gushu tablets for the treatment of middle-aged and senile osteoporosis, and Hedan tablets for promoting blood circulation and for the treatment of hyperlipidemia. The Company distributes its products in domestic market, mainly in East China, North China and Northeast China.

Sector

Pharmaceuticals

Calendar

28/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SHANDONG WOHUA PHARMACEUTICAL CO., LTD.	-33.28%	322M
DONG-E-E-JIAO CO.,LTD.	+34.14%	5.87B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-30.04%	3.71B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+1.55%	3.17B
TASLY PHARMACEUTICAL GROUP CO., LTD	-22.68%	2.71B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-8.17%	2.36B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.02%	1.89B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+45.22%	1.5B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-12.58%	1.44B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.35B